Trial Outcomes & Findings for Evaluation of PSMA Antagonist Produced by Two Different Methods (NCT NCT04685811)
NCT ID: NCT04685811
Last Updated: 2022-09-22
Results Overview
Single score Intraclass Correlation Coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying pathologic lesions. The ICC, based on a one-way random effects model was used to assess reliability. The ICC ratios in this data shows the top five lesions with the greatest PSMA uptake (SUV) in each patient. This is a measure of the variance of interest (for the patient's lesion) over the total variance (from all data points for that particular lesion of interest). Repeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The lesions reported in this analysis range from the SUV of reference organs to the average SUV of a metastatic deposit. These scans were also performed within 48 hours of each other to limit heterogeneity that may correspond to disease progression or PSMA avidity.
COMPLETED
PHASE1/PHASE2
16 participants
2 study visits between 24 to 48 hours apart
2022-09-22
Participant Flow
Participant milestones
| Measure |
Generator PSMA Scan vs Cyclotron PSMA Scan
Intraclass Correation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax.
Patients with metastatic prostate adenocarcinoma were administered a single intravenous dose approximately 100-300mBq of each of the study drugs 68Ga-PSMA-cyclotron and 68Ga-PSMA-generator 24- 48 hours apart.
Intervention Description: 68Ga-PSMA-cyclotron and 68Ga-PSMA-generator; single dose each, approximately 100-300 mBq
|
|---|---|
|
Overall Study
STARTED
|
16
|
|
Overall Study
COMPLETED
|
16
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Evaluation of PSMA Antagonist Produced by Two Different Methods
Baseline characteristics by cohort
| Measure |
ICC Between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax
|
|---|---|
|
Age, Continuous
|
73 years
n=99 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
16 Participants
n=99 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Black or African American
|
2 Participants
n=99 Participants
|
|
Race (NIH/OMB)
White
|
14 Participants
n=99 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
16 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 2 study visits between 24 to 48 hours apartSingle score Intraclass Correlation Coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying pathologic lesions. The ICC, based on a one-way random effects model was used to assess reliability. The ICC ratios in this data shows the top five lesions with the greatest PSMA uptake (SUV) in each patient. This is a measure of the variance of interest (for the patient's lesion) over the total variance (from all data points for that particular lesion of interest). Repeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The lesions reported in this analysis range from the SUV of reference organs to the average SUV of a metastatic deposit. These scans were also performed within 48 hours of each other to limit heterogeneity that may correspond to disease progression or PSMA avidity.
Outcome measures
| Measure |
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
|
|---|---|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 1
|
0.98 ICC estimate
Interval 0.94 to 0.99
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 2
|
0.98 ICC estimate
Interval 0.95 to 0.99
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 3
|
0.99 ICC estimate
Interval 0.96 to 1.0
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 4
|
0.99 ICC estimate
Interval 0.96 to 1.0
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Pathologic Lesions
Lesion 5
|
0.97 ICC estimate
Interval 0.91 to 0.99
|
PRIMARY outcome
Timeframe: 2 study visits between 24 to 48 hours apartSingle score intraclass correlation coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying average SUV Max-pathologic regions The ICC ratios in this data provides a general performance review of uptake in both pathological lesions and reference lesions, specifically the average SUVmax of bone metastases, lymph nodes, salivary glands, and the spleen.
Outcome measures
| Measure |
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
|
|---|---|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Bone Lesions
|
0.96 ICC estimate
Interval 0.88 to 0.99
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Lymph Nodes
|
0.86 ICC estimate
Interval 0.62 to 0.95
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Salivary Glands and Parotids
|
0.70 ICC estimate
Interval 0.34 to 0.88
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Average SUV Max-pathologic Regions
Average SUV Max - Spleen
|
0.82 ICC estimate
Interval 0.57 to 0.93
|
PRIMARY outcome
Timeframe: 2 study visits between 24 to 48 hours apartRepeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The intraclass correlation coefficient (ICC), based on a one-way random effects model (i.e., assumes subjects are randomly selected from the larger population), was used to assess reliability between generator and cyclotron scanning methods. BlandAltman analysis evaluated the agreement between the two scanning methods. Confidence levels of 95% were estimated to assess precision of the obtained estimates. All analyses were performed in R Version 4.0.5 (R Foundation for Statistical Computing, Vienna, Austria).
Outcome measures
| Measure |
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
|
|---|---|
|
ICC Between Generator PSMA Scan vs Cyclotron PSMA Scan: Total Lesion Average SUVMax
|
0.97 ICC estimate
|
SECONDARY outcome
Timeframe: 2 study visits between 24 to 48 hours apartSingle score intraclass correlation coefficient (ICC) was calculated as an index for reliability between 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator across varying Max SUV -pathologic regions Repeatability was evaluated by calculating the variance among group means of the SUVmean and SUVmax of each reference and lesion over the sum of the group-level and datalevel (residual) variance. The intraclass correlation coefficient (ICC), based on a one-way random effects model (i.e., assumes subjects are randomly selected from the larger population), was used to assess reliability between generator and cyclotron scanning methods. BlandAltman analysis evaluated the agreement between the two scanning methods. Confidence levels of 95% were estimated to assess precision of the obtained estimates. All analyses were performed in R Version 4.0.5 (R Foundation for Statistical Computing, Vienna, Austria).
Outcome measures
| Measure |
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
|
|---|---|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Max SUV -Pathologic Regions
Max SUV - Aorta
|
0.59 ICC estimate
Interval 0.17 to 0.84
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Max SUV -Pathologic Regions
Max SUV - Liver
|
0.91 ICC estimate
Interval 0.76 to 0.97
|
|
Evaluate Equivalence Between 68GA-PSMA-cyclotron and 68Ga-PSMA-generator Across Varying Max SUV -Pathologic Regions
Max SUV - Parotid
|
0.78 ICC estimate
Interval 0.48 to 0.92
|
SECONDARY outcome
Timeframe: 2 study visits between 24 to 48 hours apartThe biodistribution of 68GA-PSMA-cyclotron versus 68Ga-PSMA-generator will be evaluated by measuring the radioactivity concentration in various organs of interest. Based on the SUVmean and SUVmax, the RC unit will be used to compare these scans. PSMA positivity was defined as having a SUV value above that of the reference blood pool, liver, and/or salivary glands when evaluating lesions as described using the PROMISE criteria15. Quantitative analysis reviewed the SUVmax and SUVmean of the parotid gland, liver, and aortic arch (blood pool), as well as the SUVmax and SUVmean of suspected metastatic lesions. The same ROIs were evaluated on both scans for each respective patients.
Outcome measures
| Measure |
Comparison of Generator PSMA Scan vs. Cyclotron PSMA Scan
n=16 Participants
Intraclass Correlation Coefficient (ICC) between Generator PSMA Scan vs Cyclotron PSMA Scan
|
|---|---|
|
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average Coefficient Variation
|
0.97 ICC estimate
Interval 0.92 to 0.99
|
|
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average Standard Deviation
|
0.94 ICC estimate
Interval 0.85 to 0.98
|
|
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average SUV Max
|
0.97 ICC estimate
Interval 0.91 to 0.99
|
|
Compare Bio-Distribution Between 68GA-PSMA-cyclotron vs. 68Ga-PSMA-generator
Total Lesion Average SUV Mean
|
0.71 ICC estimate
Interval 0.36 to 0.89
|
Adverse Events
Generator PSMA Scan vs Cyclotron PSMA Scan
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr. Juana Martinez Zuloaga
Weill Cornell Medical College
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place